The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

Wong, Hilda; Fong Tang, Yuen; Yao, Tzy‐Jyun; Chiu, Joanne; Leung, Roland; Chan, Pierre; To Cheung, Tan; Chan, Albert; Pang, Roberta; T.P. Poon, Ronnie; Fan, Sheung-Tat; Yau, Thomas

doi:10.1634/theoncologist.2011-0192

Public

The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

Published in The Oncologist • Dec 1, 2011

Authors:

Hilda Wong

Yuen Fong Tang

Tzy‐Jyun Yao

Abstract

BACKGROUND: With the aging population, hepatocellular carcinoma (HCC) in the elderly represents a significant health burden. We aimed to evaluate and compare the efficacy and tolerability of single-agent sorafenib in treating elderly patients with advanced HCC versus the younger population. METHODS:...

Subject

Medicine

Sorafenib

Hepatocellular carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!